Join us this Thursday, 2/27, for an exciting look at the next generation of blood-based predictive biomarkers for therapy selection.

Clinicians’ Perspective on Use of Immune Checkpoint Inhibitors and Related Biomarkers for Solid Tumors

Get in touch